Toto Hølmebakk

  • Consultant
 

Publications 2021

Hølmebakk T, Boye K (2021)
Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Ann Surg Oncol (in press)
DOI 10.1245/s10434-021-09939-3, PubMed 33829360

Hølmebakk T, Boye K (2021)
ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Ann Surg Oncol
DOI 10.1245/s10434-021-09608-5, PubMed 33687615

Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
Ann Surg Oncol
DOI 10.1245/s10434-021-09605-8, PubMed 33651216

Publications 2019

Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K (2019)
Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?
Ann Surg Oncol, 26 (13), 4730-4736
DOI 10.1245/s10434-019-07813-x, PubMed 31520212

Hølmebakk T, Boye K (2019)
Author response to comment on: Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
Br J Surg, 106 (8), 1102-1103
DOI 10.1002/bjs.11245, PubMed 31260582

Hølmebakk T, Nishida T, Rutkowski P, Raut CP (2019)
Defining Rupture in Gastrointestinal Stromal Tumor: Semantics and Prognostic Value
Ann Surg Oncol, 26 (7), 2304-2305
DOI 10.1245/s10434-019-07439-z, PubMed 31076929

Nishida T, Hølmebakk T, Raut CP, Rutkowski P (2019)
Defining Tumor Rupture in Gastrointestinal Stromal Tumor
Ann Surg Oncol, 26 (6), 1669-1675
DOI 10.1245/s10434-019-07297-9, PubMed 30868512

Publications 2018

Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T (2018)
Genotype and risk of tumour rupture in gastrointestinal stromal tumour
Br J Surg, 105 (2), e169-e175
DOI 10.1002/bjs.10743, PubMed 29341147

Hølmebakk T (2018)
ASO Author Reflections: The Significance of Tumor Rupture in Gastric Gastrointestinal Stromal Tumors
Ann Surg Oncol, 25 (Suppl 3), 928-929
DOI 10.1245/s10434-018-6881-z, PubMed 30327974

Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K (2018)
Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
Br J Surg, 106 (4), 419-426
DOI 10.1002/bjs.11027, PubMed 30507040

Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K (2018)
Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
Ann Surg Oncol, 25 (5), 1133-1139
DOI 10.1245/s10434-018-6353-5, PubMed 29435684

Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS (2018)
Multimodal kreftbehandling av gastrointestinal stromal tumor
Tidsskr Nor Laegeforen, 138 (15)
DOI 10.4045/tidsskr.18.0200, PubMed 30277049

Stormorken AT, Berg T, Norum OJ, Hølmebakk T, Aaberg K, Steigen SE, Grindedal EM (2018)
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis
Fam Cancer, 17 (4), 539-543
DOI 10.1007/s10689-018-0072-8, PubMed 29368261

Publications 2017

Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K (2017)
Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort
Acta Oncol, 56 (10), 1317-1323
DOI 10.1080/0284186X.2017.1330555, PubMed 28557540

Publications 2016

Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby Hall K (2016)
Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine
Br J Surg, 103 (6), 684-691
DOI 10.1002/bjs.10104, PubMed 26988241

Publications 2011

Hølmebakk T, Solbakken A, Mala T, Nesbakken A (2011)
Clinical prediction of survival by surgeons for patients with incurable abdominal malignancy
Eur J Surg Oncol, 37 (7), 571-5
DOI 10.1016/j.ejso.2011.02.009, PubMed 21444178

Publications 2010

Hølmebakk T, Frykholm G, Viste A, Norwegian Gastrointestinal Cancer Group (NGICG) (2010)
Introducing national guidelines on perioperative chemotherapy for gastric cancer in Norway: a retrospective audit
Eur J Surg Oncol, 36 (7), 610-6
DOI 10.1016/j.ejso.2010.05.006, PubMed 20627647

Publications 2009

Frich L, Hølmebakk T (2009)
Letter 2: Randomized clinical trial of antibiotic therapy versus appendicectomy as primary treatment of acute appendicitis in unselected patients (Br J Surg 2009; 96: 473-481)
Br J Surg, 96 (10), 1224-5
DOI 10.1002/bjs.6851, PubMed 19787749

Publications 2006

Hølmebakk T, Wiig JN, Wanderås EH, Harbitz TB (2006)
[Protective silicone prosthesis prior to radiotherapy of recurrent colonic cancer]
Tidsskr Nor Laegeforen, 126 (4), 447-9
PubMed 16477282

Publications 2005

Hølmebakk T, Nesbakken A (2005)
Surgery for pilonidal disease
Scand J Surg, 94 (1), 43-6
DOI 10.1177/145749690509400111, PubMed 15865116

Publications 2003

Hølmebakk T, Nesbakken A (2003)
Operasjon for sinus pilonidalis sårinfeksjoner, tilhelingstid, residiv og kosmetisk resultat
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 72
BIBSYS 041733290

Hølmebakk T, Nesbakken A (2003)
Fra åpen til laparoskopisk appendektomi: gevinster og tap
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 92
BIBSYS 041733363

Page visits: 5